Skip to main content
Clifton Bogardus III, MD, Medical Genetics, Phoenix, AZ

Clifton Bogardus III MD


Physician

Join to View Full Profile
  • 4212 N 16th StPhoenix, AZ 85016

  • Phone+1 602-200-5200

  • Fax+1 602-200-5225

Dr. Bogardus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1981
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1977 - 1979
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 1974 - 1975
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1974

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1985 - 2025
  • VT State Medical License
    VT State Medical License 1979 - 1984
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1986

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • FGF21 Is a Hormonal Mediator of the Human “Thrifty” Metabolic Phenotype  
    Jonathan Krakoff, Clifton Bogardus, Karyne L Vinales, Diabetes Care

Lectures

  • Common Genetic Variation in Glucokinase (GCK) Is Associated with Rates of Carbohydrate Oxidation, Energy Expenditure, and Type 2 Diabetes 
    Phoenix, AZ - 6/14/2014
  • Merging Whole Genome Sequence and Tissue Expression Data to Identify cis-Acting SNPs that Affect Risk for Type 2 Diabetes and Obesity 
    Phoenix, AZ - 6/15/2014
  • Variants in the Promoter of STAM2 Are Associated with Type 2 Diabetes in Pima Indians 
    Phoenix, AZ - 6/16/2014

Press Mentions

  • Association Between Obesity and a Polymorphism in the Beta(1)-Adrenoceptor Gene (Gly389Arg ADRB1) in Caucasian Women
    Association Between Obesity and a Polymorphism in the Beta(1)-Adrenoceptor Gene (Gly389Arg ADRB1) in Caucasian WomenJuly 22nd, 2020

Grant Support

  • Gene Expression Profiling On Insulin Resistance And ObesityNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
  • Gene Expression Profiling On Insulin Resistance And ObesityNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: